Kerry Group PLC Kerry to acquire Lactase Enzymes Business (5363W)
12 Diciembre 2023 - 10:13AM
UK Regulatory
TIDMKYGA
RNS Number : 5363W
Kerry Group PLC
12 December 2023
12 December 2023
LEI: 635400TLVVBNXLFHWC59
KERRY GROUP
Kerry to acquire Lactase Enzymes Business
Kerry Group plc ("Kerry"), the global taste & nutrition
company, announces it has entered into a definitive agreement to
acquire part of the global lactase enzyme business of Chr. Hansen
Holding A/S ("Chr. Hansen") and Novozymes A/S ("Novozymes")
(together the "Lactase Enzymes Business") on a carve out basis (1).
This acquisition is subject to European Commission approval of
Kerry as a buyer and forms part of the Novozymes and Chr. Hansen
merger approval process.
The Lactase Enzymes Business which includes NOLA(R) Products,
further enhances Kerry's biotechnology solutions capability
following the acquisitions of c-LEcta and Enmex (2) . This
acquisition adds enzyme technology which helps create lactose-free
and sugar reduced dairy products, while preserving their authentic
clean taste. Global demand for lactase is being driven by increased
awareness of lactose intolerance, while many consumers are also
choosing lactose-free for lifestyle and health reasons.
The Lactase Enzymes Business had attributable revenue of
approximately EUR40m in 2022 with sales in over 50 countries. Total
consideration is EUR150m subject to routine closing adjustments,
with the acquisition expected to close in the first half of
2024.
(1) Acquisition comprises certain trade and assets of Chr.
Hansen's global lactase enzyme business and 100% of the share
capital of Nuocheng Trillion Food (Tianjin) Co., Ltd, a Chinese
subsidiary of Novozymes.
(2) Acquisition of c-LEcta GmbH completed in March 2022 and
Enmex S.A. de C.V. in December 2021.
ENDS
About Kerry
Kerry is a world leading taste and nutrition partner for the
food, beverage and pharmaceutical markets. We innovate with our
customers to create great tasting products, with improved nutrition
and functionality, while ensuring better impact for the planet. Our
leading consumer insights, global RD&A team of 1,100+ food
scientists and extensive global footprint enable us to solve our
customers' complex challenges with differentiated solutions. At
Kerry, we are driven to be our customers' most valued partner,
creating a world of sustainable nutrition, and to reach over 2
billion consumers with sustainable nutrition solutions by 2030. For
more information, visit www.kerry.com .
CONTACT INFORMATION
=============================================
Investor Relations
Marguerite Larkin , Chief Financial
Officer
+353 66 7182292 | investorrelations@kerry.ie
William Lynch , Head of Investor
Relations
+353 66 7182292 | investorrelations@kerry.ie
Media
Catherine Keogh , Chief Corporate
Affairs & Brand Officer
+353 45 930188 | corpaffairs@kerry.com
Website
www.kerry.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ACQBLBDDDBBDGXD
(END) Dow Jones Newswires
December 12, 2023 11:13 ET (16:13 GMT)
Kerry (LSE:KYGA)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Kerry (LSE:KYGA)
Gráfica de Acción Histórica
De May 2023 a May 2024